Meet Dr Nayan Kalnad, Founder at Digital Healthcare Company: Avegen

Avegen is an innovative technology company helping organisations build digital health products that empower patients to better manage long-term health conditions.

The apps and digital products we build help providers offer joined up care, give patients the support and tools they need to lead healthier lives, and generate the insights needed to shape better solutions for the future.


How did you come up with the idea for the company?

I’m a medical doctor by background and transitioned to work in pharmaceuticals, a role which saw me working to improve care delivery for HIV-positive patients in India. It was fascinating work but progress was frustratingly slow.

This was around the time when digital solutions in healthcare were starting to become more common. My next role saw me leading the cardiovascular stream for the digital innovation unit for a major pharmaceutical company in Europe.

It was here that I realised that the right technologies could transform the quality of treatment that patients with long term health conditions were receiving.

After this lightbulb moment, I teamed up with Neeraj Apte – an engineer who has over 20 years experience in software development – to create Avegen in 2015. We spent a few years exploring what the best structure for the business was and iterating our model, before doubling down on becoming the go-to development platform for scalable, compliant digital health products.

1 in 4 patients are living with long term conditions. And the cost of caring for these patients is increasing. Avegen has created a platform, called HealthMachine™, which enables healthcare providers and pharma companies to build, deploy and scale impactful digital health products quickly, to deliver better outcomes for patients and transform their lived experience of their condition.

This powerful platform now underpins digital technology used by over a million people. We’ve created products for mothers, patients recovering from cardiac bypass and patients living with long-term conditions like HIV, Tuberculosis, Pulmonary Arterial Hypertension, and Paranoia.

Today, Avegen plays an invaluable role in supporting companies and institutions the world over to deliver exceptional care through digital means.


How has the company evolved over the last couple of years?

In 2019, we evolved our original business model (which focused on delivering healthcare support more directly to patients) and concentrated our efforts on creating the world’s best platform for global partners to build and scale digital health products. That was a huge turning point for us and we’ve since gone from strength to strength.

Over the last few years we’ve massively expanded the team and now have over 70 colleagues working across the UK and India. We’ve partnered with brilliant clients and delivered game-changing digital health products that have reached more than a 1 million patients. It’s been a hugely important period for Avegen and we’re excited for what’s next.

What can we hope to see from Avegen in the future?

Our platform HealthMachine™ is on track to become the world’s leading platform for the creation of digital health products for people living with long-term conditions. Over the coming months and years we’ll be focusing on growing in new markets, expanding our talented team, and continually improving the products we create.